September 28, 2016: On September 15, Pfizer and OncoImmune inked an exclusive option and license agreement for ONC-392, a differentiated preclinical anti-CTLA4 monoclonal antibody.
September 28, 2016: Astra, with worldwide headquarters in Cambridge, UK, announced this week that it is consolidating some of its California staffers at The Cove at Oyster Point in South San Francisco.
September 28, 2016: Investors and analysts love to speculate on who Gilead might buy, but for a while, at least, one company is off limits. Galapagos, recently indicated that a standstill agreement that prevents Gilead from increasing its stake in the company is still in effect.
September 28, 2016: U2 front-man and well known philanthropist Bono, along with others, backed a $45M Series B round of funding for the Bay Area’s Color Genomics.